Lexeo Therapeutics Inc
Lexeo Therapeutics Inc (LXEO) Straddle
LXEO straddle scan found 1 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 54.4%.
Read more
Trading a LXEO straddle lets you take a pure volatility position on Lexeo Therapeutics Inc without committing to a direction. Lexeo Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate LXEO straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on LXEO profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Lexeo Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the LXEO straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease.
The company was incorporated in 2017 and is based in New York, New York.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the LXEO straddle is the cleanest expression of that view. Our scanner prices every LXEO straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a LXEO straddle into a catalyst or short a LXEO straddle to harvest decay, the options straddle setups that matter are all in one place.
| May 21, 2027 | 7.00 | $5.60 | 241 | 35% | 54.4% | $12.60 | $1.40 | 0 |
As of September 23, 2026
Find the right straddle before volatility moves
Track LXEO straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→